Bq-A Peptide Extract
Brain Death
Bioquark Inc.protein_peptidePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Brain Death cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Solu-Cortef Kuopio University Hospital | N/A | D |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →